{"id":"W3031847233","doi":"10.1200/jco.2020.38.15_suppl.tps6595","title":"Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable squamous cell carcinoma of the head and neck (SCCHN).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Lymph node; Internal medicine; Primary tumor; Oncology; Nasal cavity; Stage (stratigraphy); Melanoma; Cancer; Gastroenterology; Surgery; Immunotherapy; Metastasis; Cancer research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008354823,0.001069882,0.001395825,0.0002738052,0.0002655096,0.0008736773,0.0006442103,0.001130459,0.003485495],"category_scores_gemma":[0.0004647475,0.0003773898,0.0009758296,0.0002056387,0.0005963751,0.0009677869,0.0003589937,0.001787722,0.0006712919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007168312,"about_ca_system_score_gemma":0.0008414949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007949292,"about_ca_topic_score_gemma":0.002707341,"domain_scores_codex":[0.9997886,0.00007845955,0.00001169947,0.00003567399,0.00001705247,0.00006863238],"domain_scores_gemma":[0.9996685,0.00005620941,0.00006051094,0.00002118126,0.00001726518,0.000176373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9362949,0.01516726,0.002882054,0.0004933296,0.0006140447,0.0001574169,0.0001194799,0.0007546172,0.00944626,0.0002191174,0.001033618,0.032818],"study_design_scores_gemma":[0.6088748,0.3784637,0.007518922,0.00004357959,0.0004684071,0.0001211598,0.00007418047,0.0008941487,0.001519659,0.0002931307,0.001703882,0.00002443829],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958377,0.001297763,0.0001401509,0.0002388762,0.0001898749,0.0009100136,0.0003650475,0.00003304369,0.0009875932],"genre_scores_gemma":[0.9946206,0.0008476506,0.0004271896,0.0004291287,0.0001591109,0.001000312,0.0005550966,0.000009572028,0.001951302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003485495,"threshold_uncertainty_score":0.01166016,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.091868815051498,"score_gpt":0.3802406123352916,"score_spread":0.2883717972837936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}